nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—ABCB11—Rosuvastatin—atherosclerosis	0.0523	0.0661	CbGbCtD
Quinidine—ABCB11—Pravastatin—atherosclerosis	0.0475	0.0601	CbGbCtD
Quinidine—SLC22A5—Niacin—atherosclerosis	0.0415	0.0525	CbGbCtD
Quinidine—SLCO1A2—Rosuvastatin—atherosclerosis	0.0331	0.0419	CbGbCtD
Quinidine—SLCO1B1—Rosuvastatin—atherosclerosis	0.0313	0.0396	CbGbCtD
Quinidine—SLCO1B1—Ezetimibe—atherosclerosis	0.0313	0.0396	CbGbCtD
Quinidine—SLCO1A2—Simvastatin—atherosclerosis	0.0308	0.039	CbGbCtD
Quinidine—SLCO1A2—Pravastatin—atherosclerosis	0.0302	0.0382	CbGbCtD
Quinidine—SLCO1A2—Lovastatin—atherosclerosis	0.0302	0.0382	CbGbCtD
Quinidine—SLCO1B1—Simvastatin—atherosclerosis	0.0291	0.0368	CbGbCtD
Quinidine—SLCO1B1—Pravastatin—atherosclerosis	0.0284	0.036	CbGbCtD
Quinidine—SLCO1B1—Lovastatin—atherosclerosis	0.0284	0.036	CbGbCtD
Quinidine—ABCC2—Ezetimibe—atherosclerosis	0.0275	0.0348	CbGbCtD
Quinidine—SLC22A8—Pravastatin—atherosclerosis	0.0263	0.0332	CbGbCtD
Quinidine—ABCC2—Simvastatin—atherosclerosis	0.0255	0.0323	CbGbCtD
Quinidine—ABCC2—Pravastatin—atherosclerosis	0.025	0.0316	CbGbCtD
Quinidine—ABCC2—Lovastatin—atherosclerosis	0.025	0.0316	CbGbCtD
Quinidine—CYP3A7—Simvastatin—atherosclerosis	0.0171	0.0216	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0171	0.0216	CbGbCtD
Quinidine—CYP3A7—Lovastatin—atherosclerosis	0.0167	0.0211	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0167	0.0211	CbGbCtD
Quinidine—CYP2B6—Simvastatin—atherosclerosis	0.0162	0.0205	CbGbCtD
Quinidine—CYP2C8—Simvastatin—atherosclerosis	0.0123	0.0156	CbGbCtD
Quinidine—CYP2C8—Pravastatin—atherosclerosis	0.012	0.0152	CbGbCtD
Quinidine—CYP2C8—Lovastatin—atherosclerosis	0.012	0.0152	CbGbCtD
Quinidine—CYP2D6—Niacin—atherosclerosis	0.00993	0.0126	CbGbCtD
Quinidine—CYP2C9—Rosuvastatin—atherosclerosis	0.00923	0.0117	CbGbCtD
Quinidine—ABCB1—Ezetimibe—atherosclerosis	0.00896	0.0113	CbGbCtD
Quinidine—CYP2C9—Simvastatin—atherosclerosis	0.00858	0.0109	CbGbCtD
Quinidine—CYP2C9—Pravastatin—atherosclerosis	0.0084	0.0106	CbGbCtD
Quinidine—CYP2C9—Lovastatin—atherosclerosis	0.0084	0.0106	CbGbCtD
Quinidine—ABCB1—Simvastatin—atherosclerosis	0.00833	0.0105	CbGbCtD
Quinidine—ABCB1—Lovastatin—atherosclerosis	0.00815	0.0103	CbGbCtD
Quinidine—ABCB1—Pravastatin—atherosclerosis	0.00815	0.0103	CbGbCtD
Quinidine—CYP2D6—Simvastatin—atherosclerosis	0.00785	0.00993	CbGbCtD
Quinidine—CYP2D6—Pravastatin—atherosclerosis	0.00768	0.00971	CbGbCtD
Quinidine—CYP2D6—Lovastatin—atherosclerosis	0.00768	0.00971	CbGbCtD
Quinidine—CYP3A4—Ezetimibe—atherosclerosis	0.00537	0.00679	CbGbCtD
Quinidine—CYP3A4—Rosuvastatin—atherosclerosis	0.00537	0.00679	CbGbCtD
Quinidine—CYP3A4—Simvastatin—atherosclerosis	0.00499	0.00631	CbGbCtD
Quinidine—CYP3A4—Lovastatin—atherosclerosis	0.00488	0.00618	CbGbCtD
Quinidine—CYP3A4—Pravastatin—atherosclerosis	0.00488	0.00618	CbGbCtD
Quinidine—Haemolytic anaemia—Lovastatin—atherosclerosis	0.000805	0.00627	CcSEcCtD
Quinidine—Oesophagitis—Niacin—atherosclerosis	0.000785	0.00612	CcSEcCtD
Quinidine—Breast disorder—Rosuvastatin—atherosclerosis	0.000775	0.00604	CcSEcCtD
Quinidine—Photosensitivity—Simvastatin—atherosclerosis	0.000774	0.00603	CcSEcCtD
Quinidine—Eczema—Simvastatin—atherosclerosis	0.000756	0.00589	CcSEcCtD
Quinidine—Muscular weakness—Rosuvastatin—atherosclerosis	0.000756	0.00589	CcSEcCtD
Quinidine—Purpura—Lovastatin—atherosclerosis	0.000754	0.00587	CcSEcCtD
Quinidine—Haemolytic anaemia—Simvastatin—atherosclerosis	0.000753	0.00587	CcSEcCtD
Quinidine—Purpura—Simvastatin—atherosclerosis	0.000705	0.00549	CcSEcCtD
Quinidine—Photosensitivity—Pravastatin—atherosclerosis	0.0007	0.00545	CcSEcCtD
Quinidine—Eczema—Niacin—atherosclerosis	0.000694	0.00541	CcSEcCtD
Quinidine—Deafness—Pravastatin—atherosclerosis	0.000687	0.00535	CcSEcCtD
Quinidine—Haemolytic anaemia—Pravastatin—atherosclerosis	0.00068	0.0053	CcSEcCtD
Quinidine—Renal failure acute—Pravastatin—atherosclerosis	0.000665	0.00519	CcSEcCtD
Quinidine—Liver function test abnormal—Ezetimibe—atherosclerosis	0.000658	0.00513	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.000654	0.0051	CcSEcCtD
Quinidine—Dermatitis bullous—Niacin—atherosclerosis	0.000653	0.00509	CcSEcCtD
Quinidine—Jaundice—Rosuvastatin—atherosclerosis	0.000644	0.00502	CcSEcCtD
Quinidine—Breast disorder—Ezetimibe—atherosclerosis	0.000644	0.00502	CcSEcCtD
Quinidine—Purpura—Pravastatin—atherosclerosis	0.000637	0.00497	CcSEcCtD
Quinidine—Muscular weakness—Ezetimibe—atherosclerosis	0.000628	0.0049	CcSEcCtD
Quinidine—Diplopia—Pravastatin—atherosclerosis	0.000614	0.00479	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.000612	0.00477	CcSEcCtD
Quinidine—Muscular weakness—Simvastatin—atherosclerosis	0.000599	0.00467	CcSEcCtD
Quinidine—Hepatitis—Rosuvastatin—atherosclerosis	0.000593	0.00462	CcSEcCtD
Quinidine—Liver function test abnormal—Niacin—atherosclerosis	0.000576	0.00449	CcSEcCtD
Quinidine—Photosensitivity reaction—Lovastatin—atherosclerosis	0.000573	0.00447	CcSEcCtD
Quinidine—Orthostatic hypotension—Niacin—atherosclerosis	0.00057	0.00444	CcSEcCtD
Quinidine—Liver function test abnormal—Pravastatin—atherosclerosis	0.000567	0.00442	CcSEcCtD
Quinidine—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.000562	0.00438	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000555	0.00433	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.000553	0.00431	CcSEcCtD
Quinidine—Muscular weakness—Niacin—atherosclerosis	0.00055	0.00429	CcSEcCtD
Quinidine—Muscular weakness—Pravastatin—atherosclerosis	0.000542	0.00422	CcSEcCtD
Quinidine—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000536	0.00418	CcSEcCtD
Quinidine—Jaundice—Ezetimibe—atherosclerosis	0.000535	0.00417	CcSEcCtD
Quinidine—Angina pectoris—Niacin—atherosclerosis	0.000525	0.00409	CcSEcCtD
Quinidine—Mental disorder—Rosuvastatin—atherosclerosis	0.00052	0.00405	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000519	0.00405	CcSEcCtD
Quinidine—Angina pectoris—Pravastatin—atherosclerosis	0.000517	0.00403	CcSEcCtD
Quinidine—Jaundice—Simvastatin—atherosclerosis	0.00051	0.00398	CcSEcCtD
Quinidine—Hepatitis—Lovastatin—atherosclerosis	0.000503	0.00392	CcSEcCtD
Quinidine—Hepatitis—Ezetimibe—atherosclerosis	0.000493	0.00384	CcSEcCtD
Quinidine—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000485	0.00378	CcSEcCtD
Quinidine—Erythema multiforme—Lovastatin—atherosclerosis	0.000475	0.0037	CcSEcCtD
Quinidine—Angioedema—Rosuvastatin—atherosclerosis	0.000472	0.00368	CcSEcCtD
Quinidine—Hepatitis—Simvastatin—atherosclerosis	0.00047	0.00366	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000469	0.00366	CcSEcCtD
Quinidine—Jaundice—Niacin—atherosclerosis	0.000469	0.00365	CcSEcCtD
Quinidine—Flushing—Lovastatin—atherosclerosis	0.000466	0.00364	CcSEcCtD
Quinidine—Erythema multiforme—Ezetimibe—atherosclerosis	0.000466	0.00363	CcSEcCtD
Quinidine—Jaundice—Pravastatin—atherosclerosis	0.000461	0.0036	CcSEcCtD
Quinidine—Sweating—Niacin—atherosclerosis	0.000461	0.00359	CcSEcCtD
Quinidine—Flushing—Ezetimibe—atherosclerosis	0.000457	0.00357	CcSEcCtD
Quinidine—Chills—Lovastatin—atherosclerosis	0.000451	0.00351	CcSEcCtD
Quinidine—Immune system disorder—Ezetimibe—atherosclerosis	0.000445	0.00347	CcSEcCtD
Quinidine—Erythema multiforme—Simvastatin—atherosclerosis	0.000444	0.00346	CcSEcCtD
Quinidine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000444	0.00346	CcSEcCtD
Quinidine—Myalgia—Rosuvastatin—atherosclerosis	0.00044	0.00343	CcSEcCtD
Quinidine—Flushing—Simvastatin—atherosclerosis	0.000436	0.0034	CcSEcCtD
Quinidine—Haemoglobin—Niacin—atherosclerosis	0.000434	0.00338	CcSEcCtD
Quinidine—Mental disorder—Ezetimibe—atherosclerosis	0.000432	0.00337	CcSEcCtD
Quinidine—Haemorrhage—Niacin—atherosclerosis	0.000432	0.00336	CcSEcCtD
Quinidine—Hepatitis—Niacin—atherosclerosis	0.000432	0.00336	CcSEcCtD
Quinidine—Erythema—Ezetimibe—atherosclerosis	0.000429	0.00334	CcSEcCtD
Quinidine—Malnutrition—Ezetimibe—atherosclerosis	0.000429	0.00334	CcSEcCtD
Quinidine—Hepatitis—Pravastatin—atherosclerosis	0.000425	0.00331	CcSEcCtD
Quinidine—Confusional state—Rosuvastatin—atherosclerosis	0.000425	0.00331	CcSEcCtD
Quinidine—Chills—Simvastatin—atherosclerosis	0.000422	0.00329	CcSEcCtD
Quinidine—Visual impairment—Niacin—atherosclerosis	0.000416	0.00324	CcSEcCtD
Quinidine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000413	0.00322	CcSEcCtD
Quinidine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000413	0.00322	CcSEcCtD
Quinidine—Vision blurred—Lovastatin—atherosclerosis	0.000412	0.00321	CcSEcCtD
Quinidine—Mental disorder—Simvastatin—atherosclerosis	0.000412	0.00321	CcSEcCtD
Quinidine—Tremor—Lovastatin—atherosclerosis	0.00041	0.00319	CcSEcCtD
Quinidine—Visual impairment—Pravastatin—atherosclerosis	0.00041	0.00319	CcSEcCtD
Quinidine—Erythema—Simvastatin—atherosclerosis	0.000409	0.00319	CcSEcCtD
Quinidine—Eye disorder—Niacin—atherosclerosis	0.000403	0.00314	CcSEcCtD
Quinidine—Tinnitus—Niacin—atherosclerosis	0.000402	0.00314	CcSEcCtD
Quinidine—Erythema multiforme—Pravastatin—atherosclerosis	0.000402	0.00313	CcSEcCtD
Quinidine—Flushing—Niacin—atherosclerosis	0.000401	0.00312	CcSEcCtD
Quinidine—Angioedema—Lovastatin—atherosclerosis	0.0004	0.00312	CcSEcCtD
Quinidine—Tinnitus—Pravastatin—atherosclerosis	0.000396	0.00309	CcSEcCtD
Quinidine—Cardiac disorder—Pravastatin—atherosclerosis	0.000394	0.00307	CcSEcCtD
Quinidine—Flushing—Pravastatin—atherosclerosis	0.000394	0.00307	CcSEcCtD
Quinidine—Vertigo—Lovastatin—atherosclerosis	0.000393	0.00306	CcSEcCtD
Quinidine—Angioedema—Ezetimibe—atherosclerosis	0.000392	0.00306	CcSEcCtD
Quinidine—Leukopenia—Lovastatin—atherosclerosis	0.000392	0.00305	CcSEcCtD
Quinidine—Chills—Niacin—atherosclerosis	0.000387	0.00302	CcSEcCtD
Quinidine—Vision blurred—Simvastatin—atherosclerosis	0.000386	0.00301	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000384	0.00299	CcSEcCtD
Quinidine—Tremor—Simvastatin—atherosclerosis	0.000383	0.00299	CcSEcCtD
Quinidine—Chills—Pravastatin—atherosclerosis	0.000381	0.00297	CcSEcCtD
Quinidine—Palpitations—Ezetimibe—atherosclerosis	0.000379	0.00296	CcSEcCtD
Quinidine—Erythema—Niacin—atherosclerosis	0.000376	0.00293	CcSEcCtD
Quinidine—Malnutrition—Niacin—atherosclerosis	0.000376	0.00293	CcSEcCtD
Quinidine—Angioedema—Simvastatin—atherosclerosis	0.000374	0.00291	CcSEcCtD
Quinidine—Myalgia—Lovastatin—atherosclerosis	0.000372	0.0029	CcSEcCtD
Quinidine—Chest pain—Lovastatin—atherosclerosis	0.000372	0.0029	CcSEcCtD
Quinidine—Vertigo—Simvastatin—atherosclerosis	0.000368	0.00287	CcSEcCtD
Quinidine—Leukopenia—Simvastatin—atherosclerosis	0.000366	0.00285	CcSEcCtD
Quinidine—Chest pain—Ezetimibe—atherosclerosis	0.000365	0.00285	CcSEcCtD
Quinidine—Myalgia—Ezetimibe—atherosclerosis	0.000365	0.00285	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000363	0.00283	CcSEcCtD
Quinidine—Confusional state—Lovastatin—atherosclerosis	0.00036	0.00281	CcSEcCtD
Quinidine—Vision blurred—Niacin—atherosclerosis	0.000354	0.00276	CcSEcCtD
Quinidine—Confusional state—Ezetimibe—atherosclerosis	0.000353	0.00275	CcSEcCtD
Quinidine—Thrombocytopenia—Lovastatin—atherosclerosis	0.00035	0.00272	CcSEcCtD
Quinidine—Vision blurred—Pravastatin—atherosclerosis	0.000349	0.00272	CcSEcCtD
Quinidine—Chest pain—Simvastatin—atherosclerosis	0.000348	0.00272	CcSEcCtD
Quinidine—Myalgia—Simvastatin—atherosclerosis	0.000348	0.00272	CcSEcCtD
Quinidine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000347	0.00271	CcSEcCtD
Quinidine—Tremor—Pravastatin—atherosclerosis	0.000347	0.0027	CcSEcCtD
Quinidine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000345	0.00269	CcSEcCtD
Quinidine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000343	0.00268	CcSEcCtD
Quinidine—Angioedema—Niacin—atherosclerosis	0.000343	0.00268	CcSEcCtD
Quinidine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000343	0.00267	CcSEcCtD
Quinidine—Anorexia—Lovastatin—atherosclerosis	0.00034	0.00265	CcSEcCtD
Quinidine—Skin disorder—Ezetimibe—atherosclerosis	0.00034	0.00265	CcSEcCtD
Quinidine—Angioedema—Pravastatin—atherosclerosis	0.000338	0.00263	CcSEcCtD
Quinidine—Vertigo—Niacin—atherosclerosis	0.000338	0.00263	CcSEcCtD
Quinidine—Syncope—Niacin—atherosclerosis	0.000337	0.00263	CcSEcCtD
Quinidine—Confusional state—Simvastatin—atherosclerosis	0.000337	0.00262	CcSEcCtD
Quinidine—Leukopenia—Niacin—atherosclerosis	0.000336	0.00262	CcSEcCtD
Quinidine—Urticaria—Rosuvastatin—atherosclerosis	0.000335	0.00261	CcSEcCtD
Quinidine—Oedema—Simvastatin—atherosclerosis	0.000334	0.0026	CcSEcCtD
Quinidine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000333	0.0026	CcSEcCtD
Quinidine—Vertigo—Pravastatin—atherosclerosis	0.000332	0.00259	CcSEcCtD
Quinidine—Palpitations—Niacin—atherosclerosis	0.000332	0.00259	CcSEcCtD
Quinidine—Leukopenia—Pravastatin—atherosclerosis	0.000331	0.00258	CcSEcCtD
Quinidine—Loss of consciousness—Niacin—atherosclerosis	0.00033	0.00257	CcSEcCtD
Quinidine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000327	0.00255	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000325	0.00254	CcSEcCtD
Quinidine—Myalgia—Niacin—atherosclerosis	0.00032	0.00249	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000319	0.00249	CcSEcCtD
Quinidine—Anorexia—Simvastatin—atherosclerosis	0.000318	0.00248	CcSEcCtD
Quinidine—Dyspnoea—Lovastatin—atherosclerosis	0.000318	0.00248	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000318	0.00248	CcSEcCtD
Quinidine—Myalgia—Pravastatin—atherosclerosis	0.000315	0.00245	CcSEcCtD
Quinidine—Chest pain—Pravastatin—atherosclerosis	0.000315	0.00245	CcSEcCtD
Quinidine—Dyspnoea—Ezetimibe—atherosclerosis	0.000312	0.00243	CcSEcCtD
Quinidine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00031	0.00242	CcSEcCtD
Quinidine—Decreased appetite—Lovastatin—atherosclerosis	0.00031	0.00242	CcSEcCtD
Quinidine—Oedema—Niacin—atherosclerosis	0.000307	0.00239	CcSEcCtD
Quinidine—Confusional state—Pravastatin—atherosclerosis	0.000304	0.00237	CcSEcCtD
Quinidine—Decreased appetite—Ezetimibe—atherosclerosis	0.000304	0.00237	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000304	0.00237	CcSEcCtD
Quinidine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000302	0.00236	CcSEcCtD
Quinidine—Asthenia—Rosuvastatin—atherosclerosis	0.000302	0.00236	CcSEcCtD
Quinidine—Oedema—Pravastatin—atherosclerosis	0.000302	0.00235	CcSEcCtD
Quinidine—Shock—Niacin—atherosclerosis	0.000302	0.00235	CcSEcCtD
Quinidine—Tachycardia—Niacin—atherosclerosis	0.000299	0.00233	CcSEcCtD
Quinidine—Pruritus—Rosuvastatin—atherosclerosis	0.000298	0.00232	CcSEcCtD
Quinidine—Skin disorder—Niacin—atherosclerosis	0.000298	0.00232	CcSEcCtD
Quinidine—Dyspnoea—Simvastatin—atherosclerosis	0.000298	0.00232	CcSEcCtD
Quinidine—Hyperhidrosis—Niacin—atherosclerosis	0.000296	0.00231	CcSEcCtD
Quinidine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000296	0.0023	CcSEcCtD
Quinidine—Feeling abnormal—Lovastatin—atherosclerosis	0.000294	0.00229	CcSEcCtD
Quinidine—Anorexia—Niacin—atherosclerosis	0.000292	0.00228	CcSEcCtD
Quinidine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000292	0.00228	CcSEcCtD
Quinidine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000292	0.00227	CcSEcCtD
Quinidine—Decreased appetite—Simvastatin—atherosclerosis	0.00029	0.00226	CcSEcCtD
Quinidine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000289	0.00225	CcSEcCtD
Quinidine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000288	0.00225	CcSEcCtD
Quinidine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000288	0.00225	CcSEcCtD
Quinidine—Anorexia—Pravastatin—atherosclerosis	0.000288	0.00224	CcSEcCtD
Quinidine—Hypotension—Niacin—atherosclerosis	0.000287	0.00223	CcSEcCtD
Quinidine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000286	0.00223	CcSEcCtD
Quinidine—Urticaria—Lovastatin—atherosclerosis	0.000284	0.00221	CcSEcCtD
Quinidine—Abdominal pain—Lovastatin—atherosclerosis	0.000282	0.0022	CcSEcCtD
Quinidine—Body temperature increased—Lovastatin—atherosclerosis	0.000282	0.0022	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000279	0.00218	CcSEcCtD
Quinidine—Dizziness—Rosuvastatin—atherosclerosis	0.000279	0.00217	CcSEcCtD
Quinidine—Urticaria—Ezetimibe—atherosclerosis	0.000278	0.00217	CcSEcCtD
Quinidine—Body temperature increased—Ezetimibe—atherosclerosis	0.000277	0.00216	CcSEcCtD
Quinidine—Abdominal pain—Ezetimibe—atherosclerosis	0.000277	0.00216	CcSEcCtD
Quinidine—Feeling abnormal—Simvastatin—atherosclerosis	0.000275	0.00214	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000275	0.00214	CcSEcCtD
Quinidine—Dyspnoea—Niacin—atherosclerosis	0.000273	0.00213	CcSEcCtD
Quinidine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000273	0.00213	CcSEcCtD
Quinidine—Dyspnoea—Pravastatin—atherosclerosis	0.000269	0.0021	CcSEcCtD
Quinidine—Decreased appetite—Niacin—atherosclerosis	0.000267	0.00208	CcSEcCtD
Quinidine—Rash—Rosuvastatin—atherosclerosis	0.000266	0.00207	CcSEcCtD
Quinidine—Dermatitis—Rosuvastatin—atherosclerosis	0.000265	0.00207	CcSEcCtD
Quinidine—Urticaria—Simvastatin—atherosclerosis	0.000265	0.00207	CcSEcCtD
Quinidine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000265	0.00206	CcSEcCtD
Quinidine—Abdominal pain—Simvastatin—atherosclerosis	0.000264	0.00206	CcSEcCtD
Quinidine—Body temperature increased—Simvastatin—atherosclerosis	0.000264	0.00206	CcSEcCtD
Quinidine—Headache—Rosuvastatin—atherosclerosis	0.000264	0.00206	CcSEcCtD
Quinidine—Hypersensitivity—Lovastatin—atherosclerosis	0.000263	0.00205	CcSEcCtD
Quinidine—Decreased appetite—Pravastatin—atherosclerosis	0.000262	0.00205	CcSEcCtD
Quinidine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000258	0.00201	CcSEcCtD
Quinidine—Asthenia—Lovastatin—atherosclerosis	0.000256	0.002	CcSEcCtD
Quinidine—Pruritus—Lovastatin—atherosclerosis	0.000253	0.00197	CcSEcCtD
Quinidine—Asthenia—Ezetimibe—atherosclerosis	0.000251	0.00196	CcSEcCtD
Quinidine—Gastrointestinal pain—Niacin—atherosclerosis	0.000251	0.00195	CcSEcCtD
Quinidine—Nausea—Rosuvastatin—atherosclerosis	0.00025	0.00195	CcSEcCtD
Quinidine—Feeling abnormal—Pravastatin—atherosclerosis	0.000249	0.00194	CcSEcCtD
Quinidine—Pruritus—Ezetimibe—atherosclerosis	0.000248	0.00193	CcSEcCtD
Quinidine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000247	0.00192	CcSEcCtD
Quinidine—Hypersensitivity—Simvastatin—atherosclerosis	0.000246	0.00192	CcSEcCtD
Quinidine—Diarrhoea—Lovastatin—atherosclerosis	0.000244	0.0019	CcSEcCtD
Quinidine—Urticaria—Niacin—atherosclerosis	0.000244	0.0019	CcSEcCtD
Quinidine—Abdominal pain—Niacin—atherosclerosis	0.000242	0.00189	CcSEcCtD
Quinidine—Body temperature increased—Niacin—atherosclerosis	0.000242	0.00189	CcSEcCtD
Quinidine—Urticaria—Pravastatin—atherosclerosis	0.00024	0.00187	CcSEcCtD
Quinidine—Asthenia—Simvastatin—atherosclerosis	0.00024	0.00187	CcSEcCtD
Quinidine—Diarrhoea—Ezetimibe—atherosclerosis	0.00024	0.00187	CcSEcCtD
Quinidine—Abdominal pain—Pravastatin—atherosclerosis	0.000239	0.00186	CcSEcCtD
Quinidine—Body temperature increased—Pravastatin—atherosclerosis	0.000239	0.00186	CcSEcCtD
Quinidine—Pruritus—Simvastatin—atherosclerosis	0.000236	0.00184	CcSEcCtD
Quinidine—Dizziness—Lovastatin—atherosclerosis	0.000236	0.00184	CcSEcCtD
Quinidine—Dizziness—Ezetimibe—atherosclerosis	0.000232	0.0018	CcSEcCtD
Quinidine—Diarrhoea—Simvastatin—atherosclerosis	0.000229	0.00178	CcSEcCtD
Quinidine—Vomiting—Lovastatin—atherosclerosis	0.000227	0.00177	CcSEcCtD
Quinidine—Hypersensitivity—Niacin—atherosclerosis	0.000226	0.00176	CcSEcCtD
Quinidine—Rash—Lovastatin—atherosclerosis	0.000225	0.00175	CcSEcCtD
Quinidine—Dermatitis—Lovastatin—atherosclerosis	0.000225	0.00175	CcSEcCtD
Quinidine—Headache—Lovastatin—atherosclerosis	0.000224	0.00174	CcSEcCtD
Quinidine—Vomiting—Ezetimibe—atherosclerosis	0.000223	0.00174	CcSEcCtD
Quinidine—Hypersensitivity—Pravastatin—atherosclerosis	0.000222	0.00173	CcSEcCtD
Quinidine—Dizziness—Simvastatin—atherosclerosis	0.000221	0.00172	CcSEcCtD
Quinidine—Rash—Ezetimibe—atherosclerosis	0.000221	0.00172	CcSEcCtD
Quinidine—Dermatitis—Ezetimibe—atherosclerosis	0.000221	0.00172	CcSEcCtD
Quinidine—Asthenia—Niacin—atherosclerosis	0.00022	0.00171	CcSEcCtD
Quinidine—Headache—Ezetimibe—atherosclerosis	0.000219	0.00171	CcSEcCtD
Quinidine—Pruritus—Niacin—atherosclerosis	0.000217	0.00169	CcSEcCtD
Quinidine—Asthenia—Pravastatin—atherosclerosis	0.000217	0.00169	CcSEcCtD
Quinidine—Pruritus—Pravastatin—atherosclerosis	0.000214	0.00166	CcSEcCtD
Quinidine—Vomiting—Simvastatin—atherosclerosis	0.000212	0.00165	CcSEcCtD
Quinidine—Nausea—Lovastatin—atherosclerosis	0.000212	0.00165	CcSEcCtD
Quinidine—Rash—Simvastatin—atherosclerosis	0.000211	0.00164	CcSEcCtD
Quinidine—Dermatitis—Simvastatin—atherosclerosis	0.00021	0.00164	CcSEcCtD
Quinidine—Diarrhoea—Niacin—atherosclerosis	0.00021	0.00164	CcSEcCtD
Quinidine—Headache—Simvastatin—atherosclerosis	0.000209	0.00163	CcSEcCtD
Quinidine—Nausea—Ezetimibe—atherosclerosis	0.000208	0.00162	CcSEcCtD
Quinidine—Diarrhoea—Pravastatin—atherosclerosis	0.000207	0.00161	CcSEcCtD
Quinidine—Dizziness—Niacin—atherosclerosis	0.000203	0.00158	CcSEcCtD
Quinidine—Dizziness—Pravastatin—atherosclerosis	0.0002	0.00156	CcSEcCtD
Quinidine—Nausea—Simvastatin—atherosclerosis	0.000198	0.00155	CcSEcCtD
Quinidine—Vomiting—Niacin—atherosclerosis	0.000195	0.00152	CcSEcCtD
Quinidine—Rash—Niacin—atherosclerosis	0.000193	0.00151	CcSEcCtD
Quinidine—Dermatitis—Niacin—atherosclerosis	0.000193	0.00151	CcSEcCtD
Quinidine—Headache—Niacin—atherosclerosis	0.000192	0.0015	CcSEcCtD
Quinidine—Vomiting—Pravastatin—atherosclerosis	0.000192	0.0015	CcSEcCtD
Quinidine—Rash—Pravastatin—atherosclerosis	0.00019	0.00148	CcSEcCtD
Quinidine—Dermatitis—Pravastatin—atherosclerosis	0.00019	0.00148	CcSEcCtD
Quinidine—Headache—Pravastatin—atherosclerosis	0.000189	0.00147	CcSEcCtD
Quinidine—Nausea—Niacin—atherosclerosis	0.000182	0.00142	CcSEcCtD
Quinidine—Nausea—Pravastatin—atherosclerosis	0.000179	0.0014	CcSEcCtD
Quinidine—CYP3A4—Metabolism—APOA2—atherosclerosis	5.19e-06	6.38e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	5.19e-06	6.38e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ALOX15—atherosclerosis	5.19e-06	6.38e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—LPL—atherosclerosis	5.18e-06	6.36e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—GPX1—atherosclerosis	5.16e-06	6.34e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—NAMPT—atherosclerosis	5.13e-06	6.31e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ABCG5—atherosclerosis	5.13e-06	6.31e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—INS—atherosclerosis	5.12e-06	6.29e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—ALB—atherosclerosis	5.11e-06	6.29e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—APOB—atherosclerosis	5.11e-06	6.28e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—INS—atherosclerosis	5.11e-06	6.28e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.1e-06	6.27e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—LIPC—atherosclerosis	5.1e-06	6.27e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—LPL—atherosclerosis	5.09e-06	6.25e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—APOC3—atherosclerosis	5.07e-06	6.23e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—GPX1—atherosclerosis	5.05e-06	6.21e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—LDLR—atherosclerosis	5.04e-06	6.19e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CG—atherosclerosis	5.03e-06	6.19e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CD36—atherosclerosis	5.02e-06	6.17e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—GSTM1—atherosclerosis	4.97e-06	6.11e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—ABCA1—atherosclerosis	4.97e-06	6.11e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—LPA—atherosclerosis	4.95e-06	6.09e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	4.95e-06	6.08e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CETP—atherosclerosis	4.92e-06	6.05e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CD36—atherosclerosis	4.92e-06	6.05e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—HMOX1—atherosclerosis	4.89e-06	6.01e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—NOS3—atherosclerosis	4.89e-06	6.01e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—LPL—atherosclerosis	4.88e-06	6e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PPARG—atherosclerosis	4.85e-06	5.97e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—SPP1—atherosclerosis	4.82e-06	5.92e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—BGN—atherosclerosis	4.8e-06	5.9e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	4.8e-06	5.9e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—INS—atherosclerosis	4.76e-06	5.86e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—GPX1—atherosclerosis	4.76e-06	5.85e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—MTHFR—atherosclerosis	4.76e-06	5.85e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—APOA5—atherosclerosis	4.75e-06	5.84e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—SCARB1—atherosclerosis	4.71e-06	5.79e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.7e-06	5.77e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—ALB—atherosclerosis	4.69e-06	5.77e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—APOB—atherosclerosis	4.69e-06	5.76e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—ALB—atherosclerosis	4.68e-06	5.76e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—ABCA1—atherosclerosis	4.68e-06	5.76e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PPARA—atherosclerosis	4.67e-06	5.74e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—MTHFR—atherosclerosis	4.66e-06	5.73e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—ABCA1—atherosclerosis	4.64e-06	5.71e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CD36—atherosclerosis	4.64e-06	5.7e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.59e-06	5.64e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PPARA—atherosclerosis	4.57e-06	5.62e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	4.57e-06	5.62e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—GSTM1—atherosclerosis	4.56e-06	5.6e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—AGT—atherosclerosis	4.52e-06	5.56e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—NOS3—atherosclerosis	4.49e-06	5.52e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—NOS3—atherosclerosis	4.48e-06	5.51e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—LPL—atherosclerosis	4.47e-06	5.5e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PTGS2—atherosclerosis	4.47e-06	5.5e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	4.46e-06	5.48e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—HMGCR—atherosclerosis	4.45e-06	5.47e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—APOE—atherosclerosis	4.43e-06	5.45e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—AGT—atherosclerosis	4.43e-06	5.44e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ALOX5—atherosclerosis	4.41e-06	5.43e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—MTHFR—atherosclerosis	4.39e-06	5.4e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CAV1—atherosclerosis	4.39e-06	5.4e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—APOA1—atherosclerosis	4.38e-06	5.38e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—ALB—atherosclerosis	4.37e-06	5.37e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—GPX1—atherosclerosis	4.36e-06	5.37e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—AGT—atherosclerosis	4.35e-06	5.35e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—APOE—atherosclerosis	4.34e-06	5.33e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PPARA—atherosclerosis	4.31e-06	5.3e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CAV1—atherosclerosis	4.3e-06	5.29e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—APOA1—atherosclerosis	4.29e-06	5.27e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—APOE—atherosclerosis	4.26e-06	5.24e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—LEP—atherosclerosis	4.26e-06	5.24e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—HMOX1—atherosclerosis	4.26e-06	5.24e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CD36—atherosclerosis	4.25e-06	5.23e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CAV1—atherosclerosis	4.22e-06	5.19e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—APOA1—atherosclerosis	4.21e-06	5.18e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—NOS3—atherosclerosis	4.18e-06	5.13e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—AGT—atherosclerosis	4.17e-06	5.13e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PTGS2—atherosclerosis	4.1e-06	5.05e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PTGS2—atherosclerosis	4.1e-06	5.04e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—APOE—atherosclerosis	4.09e-06	5.03e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—APOB—atherosclerosis	4.08e-06	5.02e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—ESR1—atherosclerosis	4.07e-06	5.01e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CAV1—atherosclerosis	4.05e-06	4.98e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—APOA1—atherosclerosis	4.04e-06	4.97e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—MTHFR—atherosclerosis	4.03e-06	4.95e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—F2—atherosclerosis	4.02e-06	4.94e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—HMOX1—atherosclerosis	4.02e-06	4.94e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.01e-06	4.93e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CG—atherosclerosis	4e-06	4.92e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—HMOX1—atherosclerosis	3.98e-06	4.9e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GSTM1—atherosclerosis	3.97e-06	4.88e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—ABCA1—atherosclerosis	3.97e-06	4.88e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—NAMPT—atherosclerosis	3.96e-06	4.87e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PPARA—atherosclerosis	3.95e-06	4.86e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—LIPC—atherosclerosis	3.93e-06	4.84e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CG—atherosclerosis	3.92e-06	4.81e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—APOC3—atherosclerosis	3.91e-06	4.81e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—LPL—atherosclerosis	3.9e-06	4.79e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—LDLR—atherosclerosis	3.89e-06	4.78e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PPARG—atherosclerosis	3.86e-06	4.74e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	3.85e-06	4.73e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—APOB—atherosclerosis	3.85e-06	4.73e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—AGT—atherosclerosis	3.83e-06	4.71e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PTGS2—atherosclerosis	3.82e-06	4.7e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—APOB—atherosclerosis	3.81e-06	4.69e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GPX1—atherosclerosis	3.8e-06	4.68e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CETP—atherosclerosis	3.8e-06	4.67e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—INS—atherosclerosis	3.78e-06	4.65e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PPARG—atherosclerosis	3.78e-06	4.65e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—APOE—atherosclerosis	3.75e-06	4.61e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GSTM1—atherosclerosis	3.74e-06	4.6e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CAV1—atherosclerosis	3.72e-06	4.57e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GSTM1—atherosclerosis	3.71e-06	4.56e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—APOA1—atherosclerosis	3.71e-06	4.56e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—INS—atherosclerosis	3.71e-06	4.56e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CD36—atherosclerosis	3.7e-06	4.55e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CG—atherosclerosis	3.69e-06	4.54e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	3.68e-06	4.53e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—LPL—atherosclerosis	3.67e-06	4.52e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—INS—atherosclerosis	3.64e-06	4.48e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—LPL—atherosclerosis	3.64e-06	4.48e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—SCARB1—atherosclerosis	3.64e-06	4.47e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CCL2—atherosclerosis	3.58e-06	4.41e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GPX1—atherosclerosis	3.58e-06	4.41e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PPARG—atherosclerosis	3.56e-06	4.38e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GPX1—atherosclerosis	3.55e-06	4.37e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IGF1—atherosclerosis	3.52e-06	4.33e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—MTHFR—atherosclerosis	3.51e-06	4.32e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—INS—atherosclerosis	3.49e-06	4.3e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CD36—atherosclerosis	3.49e-06	4.29e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—ALB—atherosclerosis	3.47e-06	4.27e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CD36—atherosclerosis	3.46e-06	4.25e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PPARA—atherosclerosis	3.44e-06	4.23e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—HMGCR—atherosclerosis	3.43e-06	4.22e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—HMOX1—atherosclerosis	3.4e-06	4.18e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—ALB—atherosclerosis	3.4e-06	4.18e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CG—atherosclerosis	3.38e-06	4.16e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	3.35e-06	4.11e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—AGT—atherosclerosis	3.33e-06	4.1e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—NOS3—atherosclerosis	3.32e-06	4.08e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—MTHFR—atherosclerosis	3.31e-06	4.07e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—MTHFR—atherosclerosis	3.28e-06	4.03e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—APOE—atherosclerosis	3.27e-06	4.02e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PPARG—atherosclerosis	3.27e-06	4.02e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—APOB—atherosclerosis	3.26e-06	4.01e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—NOS3—atherosclerosis	3.25e-06	4e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PPARA—atherosclerosis	3.24e-06	3.99e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CAV1—atherosclerosis	3.24e-06	3.98e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—APOA1—atherosclerosis	3.23e-06	3.97e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PPARA—atherosclerosis	3.22e-06	3.95e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—INS—atherosclerosis	3.2e-06	3.94e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—ALB—atherosclerosis	3.2e-06	3.94e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NOS3—atherosclerosis	3.19e-06	3.93e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GSTM1—atherosclerosis	3.17e-06	3.9e-05	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—AKT1—atherosclerosis	3.15e-06	3.87e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—AGT—atherosclerosis	3.14e-06	3.86e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—AGT—atherosclerosis	3.11e-06	3.83e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—LPL—atherosclerosis	3.11e-06	3.83e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—APOE—atherosclerosis	3.08e-06	3.79e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—NOS3—atherosclerosis	3.06e-06	3.77e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ABCA1—atherosclerosis	3.06e-06	3.76e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—APOE—atherosclerosis	3.05e-06	3.75e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CAV1—atherosclerosis	3.05e-06	3.75e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—APOA1—atherosclerosis	3.04e-06	3.74e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GPX1—atherosclerosis	3.04e-06	3.73e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PTGS2—atherosclerosis	3.03e-06	3.73e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CAV1—atherosclerosis	3.02e-06	3.72e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—APOA1—atherosclerosis	3.02e-06	3.71e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PTGS2—atherosclerosis	2.97e-06	3.66e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CD36—atherosclerosis	2.96e-06	3.64e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CG—atherosclerosis	2.95e-06	3.63e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—ALB—atherosclerosis	2.94e-06	3.61e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PPARG—atherosclerosis	2.85e-06	3.5e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	2.83e-06	3.48e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—NOS3—atherosclerosis	2.81e-06	3.45e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PTGS2—atherosclerosis	2.8e-06	3.45e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—MTHFR—atherosclerosis	2.8e-06	3.44e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—INS—atherosclerosis	2.79e-06	3.43e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	2.78e-06	3.42e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	2.75e-06	3.39e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PPARA—atherosclerosis	2.75e-06	3.38e-05	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	2.74e-06	3.37e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—IL6—atherosclerosis	2.69e-06	3.31e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PPARG—atherosclerosis	2.68e-06	3.3e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—AGT—atherosclerosis	2.66e-06	3.27e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PPARG—atherosclerosis	2.66e-06	3.27e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—INS—atherosclerosis	2.63e-06	3.23e-05	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—AKT1—atherosclerosis	2.63e-06	3.23e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.63e-06	3.23e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—APOE—atherosclerosis	2.61e-06	3.21e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—INS—atherosclerosis	2.61e-06	3.21e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CAV1—atherosclerosis	2.58e-06	3.18e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—APOA1—atherosclerosis	2.58e-06	3.17e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PTGS2—atherosclerosis	2.57e-06	3.16e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MMP9—atherosclerosis	2.56e-06	3.15e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—ALB—atherosclerosis	2.56e-06	3.15e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	2.54e-06	3.12e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—APOB—atherosclerosis	2.51e-06	3.09e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	2.49e-06	3.06e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	2.49e-06	3.06e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—NOS3—atherosclerosis	2.45e-06	3.01e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.45e-06	3.01e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—ALB—atherosclerosis	2.41e-06	2.96e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—LPL—atherosclerosis	2.4e-06	2.95e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—ALB—atherosclerosis	2.39e-06	2.94e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	2.35e-06	2.89e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GPX1—atherosclerosis	2.34e-06	2.88e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—NOS3—atherosclerosis	2.31e-06	2.84e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	2.3e-06	2.83e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—NOS3—atherosclerosis	2.29e-06	2.81e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CD36—atherosclerosis	2.28e-06	2.81e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—STAT3—atherosclerosis	2.28e-06	2.8e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PPARG—atherosclerosis	2.27e-06	2.79e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—AKT1—atherosclerosis	2.25e-06	2.76e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PTGS2—atherosclerosis	2.24e-06	2.75e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—INS—atherosclerosis	2.23e-06	2.74e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	2.18e-06	2.68e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.16e-06	2.66e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PPARA—atherosclerosis	2.12e-06	2.61e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	2.11e-06	2.6e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.11e-06	2.59e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.09e-06	2.57e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—AKT1—atherosclerosis	2.06e-06	2.54e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—AKT1—atherosclerosis	2.06e-06	2.53e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—AGT—atherosclerosis	2.05e-06	2.53e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—ALB—atherosclerosis	2.04e-06	2.51e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—APOE—atherosclerosis	2.01e-06	2.48e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CAV1—atherosclerosis	1.99e-06	2.45e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—APOA1—atherosclerosis	1.99e-06	2.45e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—NOS3—atherosclerosis	1.95e-06	2.4e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—AKT1—atherosclerosis	1.92e-06	2.36e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.82e-06	2.23e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.79e-06	2.2e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PPARG—atherosclerosis	1.75e-06	2.16e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—INS—atherosclerosis	1.72e-06	2.11e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IL6—atherosclerosis	1.59e-06	1.96e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ALB—atherosclerosis	1.58e-06	1.94e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—AKT1—atherosclerosis	1.53e-06	1.88e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—NOS3—atherosclerosis	1.51e-06	1.85e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—AKT1—atherosclerosis	1.49e-06	1.84e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—AKT1—atherosclerosis	1.47e-06	1.81e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—AKT1—atherosclerosis	1.41e-06	1.73e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.38e-06	1.7e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—AKT1—atherosclerosis	1.29e-06	1.59e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—AKT1—atherosclerosis	1.13e-06	1.38e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—AKT1—atherosclerosis	1.06e-06	1.3e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—AKT1—atherosclerosis	1.05e-06	1.29e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—AKT1—atherosclerosis	8.98e-07	1.1e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—AKT1—atherosclerosis	6.93e-07	8.52e-06	CbGpPWpGaD
